| 2021年年报 | 2021年中报 | 2020年年报 | 2020年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 分部间抵销(元) | - | -27,080,830.75 | - | -27,290,463.80 |
| 药品研发服务(元) | 324,126,938.07 | 135,684,497.22 | 238,790,715.73 | 81,931,821.04 |
| 医药商品流通(元) | 102,895,135.72 | 67,616,350.65 | 88,618,611.17 | 35,994,875.46 |
| 医药制造业(元) | 1,174,664,529.38 | 574,417,082.64 | 1,088,288,342.62 | 556,991,120.74 |
| 其他(元) | - | 1,234,798.93 | - | - |
| 营业成本(元) | ||||
| 分部间抵销(元) | - | -26,657,657.66 | - | -27,290,463.80 |
| 药品研发服务(元) | 170,619,720.33 | 74,408,594.54 | 119,455,630.77 | 42,887,315.34 |
| 医药商品流通(元) | 99,469,719.46 | 63,347,209.69 | 82,158,128.58 | 32,496,521.00 |
| 医药制造业(元) | 870,180,999.21 | 428,273,394.97 | 840,472,159.40 | 363,180,212.82 |
| 其他(元) | - | 306,994.07 | - | - |
| 毛利(元) | ||||
| 分部间抵销(元) | - | -423,173.09 | - | - |
| 药品研发服务(元) | 153,507,217.74 | 61,275,902.68 | 119,335,084.96 | 39,044,505.70 |
| 医药商品流通(元) | 3,425,416.26 | 4,269,140.96 | 6,460,482.59 | 3,498,354.46 |
| 医药制造业(元) | 304,483,530.17 | 146,143,687.67 | 247,816,183.22 | 193,810,907.92 |
| 其他(元) | - | 927,804.86 | - | - |
| 毛利率(%) | ||||
| 分部间抵销(%) | - | 1.56 | - | - |
| 药品研发服务(%) | 47.36 | 45.16 | 49.97 | 47.65 |
| 医药商品流通(%) | 3.33 | 6.31 | 7.29 | 9.72 |
| 医药制造业(%) | 25.92 | 25.44 | 22.77 | 34.80 |
| 其他(%) | - | 75.14 | - | - |
| 收入构成(%) | ||||
| 分部间抵销(%) | - | -3.60 | - | -4.21 |
| 药品研发服务(%) | 20.24 | 18.05 | 16.87 | 12.65 |
| 医药商品流通(%) | 6.42 | 8.99 | 6.26 | 5.56 |
| 医药制造业(%) | 73.34 | 76.40 | 76.87 | 86.00 |
| 其他(%) | - | 0.16 | - | - |
| 毛利构成(%) | ||||
| 分部间抵销(%) | - | -0.20 | - | 0.00 |
| 药品研发服务(%) | 33.27 | 28.88 | 31.94 | 16.52 |
| 医药商品流通(%) | 0.74 | 2.01 | 1.73 | 1.48 |
| 医药制造业(%) | 65.99 | 68.87 | 66.33 | 82.00 |
| 其他(%) | - | 0.44 | - | - |
